SHE, 002653 End of Day and Historical Stock Data []

The worlds #1 website for end of day & historical stock data

wide range of exchanges, data formats, tools and services

APINEW HISTORICAL DATA SYMBOL LISTS MEMBERSHIP REGISTER LOG IN

SHE, 002653: Xizang Haisco Pharmaceutical Group Co Ltd

28 Aug 2025

LAST: 55.49	CHANGE: 0.01	OPEN: 55.28	HIGH: 56.37	ASK: 0.00	VOLUME: 5.07M
LAST: 55.49	CHG(%): 0.02	PREV: 55.48	LOW: 54.12	BID: 0.00

CHART

Period:

RECENT END OF DAY PRICES

Date	Open	High	Low	Close	Volume
28 Aug 25	55.28	56.37	54.12	55.49	5.07M
27 Aug 25	59.89	59.89	55.22	55.48	8.63M
26 Aug 25	59.40	60.79	59.10	60.50	3.59M
25 Aug 25	59.04	60.30	58.50	59.40	4.86M
22 Aug 25	58.93	59.33	58.12	58.80	3.39M
21 Aug 25	58.86	59.50	58.00	58.80	3.64M
20 Aug 25	58.50	59.08	57.00	58.88	3.8M
19 Aug 25	58.66	61.00	58.50	58.80	4.31M
18 Aug 25	60.30	60.30	58.00	58.88	6.06M
15 Aug 25	59.51	60.83	58.22	60.30	4.75M

COMPANY PROFILE

Name:	Xizang Haisco Pharmaceutical Group Co Ltd
About:	Haisco Pharmaceutical Group Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products in China. The company offers anesthetic analgesic, neuropsychiatric system, and digestive liver and parenteral nutrition medications; drugs for the endocrine and cardiovascular system; oncology-related drugs; andrology drugs; desonide and liprocaine cream; propofol medium/long chain fat emulsion and hydroxyethyl starch sodium chloride injection; sodium fusidicate ointment; lupatadine fumarate tablets; and caspofungin acetate and methylprednisolone sodium succinate for injection. It also develops Sisuning for sedation and anesthesia during surgery/procedure for non-endotracheal intubation, general anesthesia induction and maintenance, sedation in mechanical ventilation during intensive care, pediatric indications, and general anesthesia induction; Simenine for diabetic peripheral neuralgia, postherpetic neuralgia, and central nervous system analgesia; Beichangping for type 2 diabetes; Sysojing for postoperative analgesia of abdominal surgery, chronic kidney disease itching, orthopedic analgesia, and postoperative nausea and vomiting; HSK31858 for non-cystic fibrosis bronchiectasis, bronchial asthma, chronic obstructive pulmonary disease, and expectorant; HSK31679 for nonalcoholic steatohepatitis; HSK39297 for PHN of hemolytic disease and primary or secondary glomerular disease; HSK39775 and HSK42360 for advanced solid tumors; HSK39004 and HL231 for chronic obstructive pulmonary disease; HSK44459 for interstitial lung disease; HSK46575 for prostate cancer; and HSK41959 for advanced solid tumors. It offers its products for anesthesia, analgesia, chronic metabolic, respiratory, autoimmune diseases, etc. The company was formerly known as Xizang Haisco Pharmaceutical Group Co., Ltd. and changed its name to Haisco Pharmaceutical Group Co., Ltd. in March 2016. Haisco Pharmaceutical Group Co., Ltd. was founded in 2005 and is based in Shannan, China.
Sector:	Healthcare
Industry:	Biotechnology
Address:	No.17, Sanxiang Avenue, Shannan, China, 856000
Website:	https://www.haisco.com
ISIN:	CNE100001BC7

SYMBOL HISTORY

Purchase End of Day History
for this symbol from Jan 01, 0001

Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

Exchange:

Format:

Period:

Zip file

Symbol:

Start Date:

End Date:

FUNDAMENTALS

P/E Ratio:	190.10
DivYield:	0.00
Div/Share:	0.27
PtB:	16.00
PtS:	16.35
EBITDA:	420.72M
Shares:	1.12B
Market Cap:	62.144B

TECHNICAL INDICATORS

MA5:	57.93
MA10:	58.53
MA20:	57.52
MA50:	50.76
MA100:	47.21
MA200:	40.68
STO9:	0.18
STO14:	0.14
RSI14:	37.35
WPR14:	-99.80
MTM14:	-1.48
ROC14:	-0.03
ATR:	2.69
Week High:	60.79
Week Low:	54.12
Month High:	62.65
Month Low:	50.52
Year High:	62.65
Year Low:	29.13